环氧化酶-1、环氧化酶-2：那又怎样？

Scand J Rheumatol. 1999;28(1):6-9. doi: 10.1080/03009749950155715.

The discovery of the second isoform of cycloxygenase has led to a rapid expansion in basic science, pharmacology and clinical data. With the completion of phase II studies of the new COX-2 specific inhibitors this review examines some of the implications of the new data.

环氧化酶第二种同工型的发现促使基础科学、药理学及临床数据迅速扩充。随着新型COX-2特异性抑制剂II期研究的完成，本综述探讨了这些新数据的一些影响。